Chronic Myeloid Leukemia in Adolescents and Young Adults Treated with Generic Form of Imatinib in Resource Limited Setting: A Single Center Experience from Myanmar

被引：0
|
作者：
Han, Yin Nwe [1 ]
Gyi, Aye Aye [1 ,2 ]
Htut, Khin Thida [2 ]
机构：
[1] North Okkalapa Gen & Teaching Hosp, Dept Clin Haematol, Yangon, Myanmar
[2] North Okkalapa Gen & Teaching Hosp, Yangon, Myanmar
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-120298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5451
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Complete Molecular Response in Chronic Myeloid Leukemia After Six Months of Imatinib: A Single Center Experience
    Saleem, Umera
    Hafeez, Talha
    Raza, Syed Ali
    Tahir, Muhammad
    Khalid, Fatima
    Islam, Muhammad Khurrum
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
  • [22] Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
    Abou Dalle, Iman
    Kantarjian, Hagop
    Burger, Jan
    Estrov, Zeev
    Ohanian, Maro
    Verstovsek, Srdan
    Ravandi, Farhad
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Cortes, Jorge
    CANCER MEDICINE, 2019, 8 (15): : 6559 - 6565
  • [23] Cardiac events in imatinib mesylate-treated chronic myeloid leukemia patients: A single institution experience
    Breccia, Massimo
    Cannella, Laura
    Frustaci, Annamaria
    Stefanizzi, Caterina
    Levi, Anna
    Alimena, Giuliana
    LEUKEMIA RESEARCH, 2008, 32 (05) : 835 - 836
  • [24] MANAGING CHILDREN AND ADOLESCENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH HIGH-DOSE IMATINIB. THE ITALIAN EXPERIENCE
    Giona, F.
    Saglio, G.
    Santopietro, M.
    Menna, G.
    Putti, M. C.
    Micalizzi, C.
    Grazia, I.
    Santoro, N.
    Ladogana, S.
    Mura, R. M.
    Burnelli, R.
    Consarino, C.
    Cosmi, C.
    Moleti, M. L.
    Varotto, S.
    Tucci, F.
    Nanni, M.
    Diverio, D.
    Biondi, A.
    Locatelli, F.
    Foa, R.
    HAEMATOLOGICA, 2016, 101 : 64 - 65
  • [25] Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy
    Bonifacio, Massimiliano
    Scaffidi, Luigi
    Binotto, Gianni
    Miggiano, Maria Cristina
    Danini, Marco
    Minotto, Claudia
    Griguolo, Davide
    Marin, Luciana
    Frison, Luca
    D'Amore, Fabio
    Basso, Marco
    Sartori, Roberto
    Tinelli, Martina
    Stulle, Manuela
    Fortuna, Stefania
    Bonalumi, Angela
    Bertoldero, Giovanni
    De Biasi, Ercole
    Ruggeri, Marco
    Semenzato, Gianpietro
    Fanin, Renato
    Pizzolo, Giovanni
    Krampera, Mauro
    Tiribelli, Mario
    LEUKEMIA RESEARCH, 2018, 74 : 75 - 79
  • [26] Hematologic, cytogenetic, and molecular responses to imatinib therapy for chronic myeloid leukemia: a single-center experience in Turkey
    Bilen, Yusuf
    Erdem, Fuat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (01) : 31 - 38
  • [27] Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center
    Dou, Xuelin
    Qin, Yazhen
    Lai, Yueyun
    Shi, Hongxia
    Huang, Xiaojun
    Jiang, Qian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (06): : E304 - E315
  • [28] Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China
    Yuli Cai
    Chao Liu
    Ye Guo
    Xiaojuan Chen
    Li Zhang
    Yumei Chen
    Yao Zou
    Wenyu Yang
    Xiaofan Zhu
    International Journal of Hematology, 2021, 113 : 413 - 421
  • [29] Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China
    Cai, Yuli
    Liu, Chao
    Guo, Ye
    Chen, Xiaojuan
    Zhang, Li
    Chen, Yumei
    Zou, Yao
    Yang, Wenyu
    Zhu, Xiaofan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 413 - 421
  • [30] Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country
    Medhi, Kunjahari
    Raina, Vinod
    Kumar, Lalit
    Sharma, Atul
    Bakhshi, Sameer
    Gupta, Ritu
    Kumar, Rajive
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1850 - 1854
12345